Jonathan Weinbach, NYPC’s Chief Executive Officer, and Dr. Charles B. Simone II, Chief Medical Officer, spoke with Manhattan Times about the Center’s 3,000thpatient milestone, the benefits of proton therapy, and new research studies. Read the full story at Manhattan Times.